AzTrials
AzTrials

Hernia, InguinalTAPPHCO3NCT07473583

Pneumoperitoneum Duration and Bicarbonate Changes in Laparoscopic Hernia Surgery

An observational study of Hernia, Inguinal and Inguinal Hernia, run by Haseki Training and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn how the length of pneumoperitoneum during laparoscopic inguinal hernia surgery may affect changes in blood bicarbonate levels. Pneumoperitoneum is the use of carbon dioxide gas to create space inside the abdomen during laparoscopic surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hernia, Inguinal, Inguinal Hernia
What is being tested?
Laparoscopic Inguinal Hernia Repair (TAPP)
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Mar 2026to May 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients undergoing laparoscopic inguinal hernia repair (TAPP) at Haseki Training and Research Hospital will be included. Perioperative pneumoperitoneum duration and serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.

Who may be able to join

  • Age ≥18 years
  • Patients undergoing laparoscopic inguinal hernia repair using the TAPP technique
  • Ability to provide informed consent

Who cannot join

  • Pregnancy
  • Severe cardiovascular disease
  • Renal insufficiency
  • Patients requiring additional intra-abdominal surgical procedures
  • Strangulated inguinal hernia requiring bowel resection

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bahar Canbay Torun, MD contact

+90 505 389 0489

baharcanbay@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Haseki Training and Research Hospital

    Istanbul, 34265

    Muzaffer Akinci, MD, +90 532 431 3613, muzoakinci@hotmail.com

    Bahar Canbay Torun, MD, +90 505 389 0489, baharcanbay@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Association Between Pneumoperitoneum Duration and Changes in Serum Bicarbonate Levels in Patients Undergoing Laparoscopic Inguinal Hernia Repair: A Prospective Observational Study

The goal of this observational study is to learn how the length of pneumoperitoneum during laparoscopic inguinal hernia surgery may affect changes in blood bicarbonate levels. Pneumoperitoneum is the use of carbon dioxide gas to create space inside the abdomen during laparoscopic surgery.

The main question this study aims to answer is whether a longer pneumoperitoneum time is associated with changes in blood bicarbonate levels after surgery.

Read more

Participants are adults undergoing laparoscopic inguinal hernia repair as part of their routine medical care. Researchers will measure blood gas values, including bicarbonate levels, before surgery and again two hours after surgery. The change in bicarbonate levels will be compared with the duration of pneumoperitoneum during the operation.

The results of this study may help improve the understanding of metabolic changes that occur during laparoscopic surgery.

Read the detailed description

Carbon dioxide pneumoperitoneum is routinely used during laparoscopic surgery to provide adequate visualization and working space. However, absorption of carbon dioxide and increased intra-abdominal pressure may influence acid-base balance during the perioperative period. These physiological changes may be reflected in blood gas parameters such as pH, partial pressure of carbon dioxide (pCO2), and serum bicarbonate levels.

This prospective observational study aims to evaluate the relationship between pneumoperitoneum duration and perioperative changes in serum bicarbonate levels in patients undergoing laparoscopic inguinal hernia repair using the transabdominal preperitoneal (TAPP) technique.

Adult patients undergoing elective laparoscopic inguinal hernia repair will be included in the study. Blood gas measurements will be obtained before surgery and at the second postoperative hour. Serum bicarbonate levels will be recorded, and the difference between preoperative and postoperative measurements (ΔHCO3-) will be calculated.

The primary outcome of the study is the change in serum bicarbonate levels between the preoperative and postoperative second-hour measurements. Secondary outcomes include postoperative pain scores, postoperative acid-base parameters such as pH and pCO2, and early postoperative complications within the first 24 hours.

Pneumoperitoneum duration will be recorded intraoperatively and analyzed for its association with perioperative metabolic changes. The findings of this study may contribute to a better understanding of metabolic alterations occurring during laparoscopic surgery and their potential clinical implications.

Being tested
Laparoscopic Inguinal Hernia Repair (TAPP)
Keywords
Pneumoperitoneum, Laparoscopic Inguinal Hernia Repair, Serum Bicarbonate, Blood Gas Analysis, TAPP Technique
Medical subject headings
Hernia, Inguinal, Pneumoperitoneum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic Inguinal Hernia Repair (TAPP)Procedure or surgery

    Standard laparoscopic inguinal hernia repair performed using the transabdominal preperitoneal (TAPP) technique as part of routine clinical care. Pneumoperitoneum duration during the procedure will be recorded for analysis.

Study groups in NCT07473583
Study groupRoleWhat they receive
Laparoscopic Inguinal Hernia PatientsAdult patients undergoing laparoscopic inguinal hernia repair (TAPP). Pneumoperitoneum duration and perioperative serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.
Receives: Procedure: Laparoscopic Inguinal Hernia Repair (TAPP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Serum Bicarbonate Level

    Difference between preoperative and postoperative second-hour serum bicarbonate levels measured by blood gas analysis in patients undergoing laparoscopic inguinal hernia repair.

    Unit of Measure: mmol/L

    Measured: Preoperative to postoperative 2 hours

Secondary outcomes (4)
  1. Postoperative Pain Score

    Postoperative pain intensity measured using the Visual Analog Scale (VAS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores represent greater pain severity.

    Unit of Measure: VAS score (0-10)

    Measured: Within 24 hours after surgery

  2. Change in Arterial Blood pH

    Change in arterial blood pH measured during pneumoperitoneum.

    Unit of Measure: pH

    Measured: Preoperative to postoperative 2 hours

  3. Early Postoperative Complications

    Early postoperative complications occurring within the first 24 hours after laparoscopic inguinal hernia repair.

    Measured: Within 24 hours

  4. Change in Arterial Partial Pressure of Carbon Dioxide

    Change in arterial PaCO₂ levels measured intraoperatively.

    Unit of Measure: mmHg

    Measured: Preoperative to postoperative 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start10 Mar 2026 (estimated)
  3. Primary completionApr 2026 (estimated)
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07473583
Sponsor's protocol ID
HASEKI-305-2025
Acronym
TAPPHCO3
Status last verified
Mar 2026
First submitted
6 Mar 2026
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to institutional data protection policies and patient confidentiality requirements. Only aggregated and anonymized data will be reported in scientific publications.

Questions about this trial

What is this clinical trial studying?

An observational study of Hernia, Inguinal and Inguinal Hernia, run by Haseki Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Osman Sibic, MD (+90 534 617 72 53, osmansibic@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Serum Bicarbonate Level (time frame: Preoperative to postoperative 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in